SKAN Group AG - Asset Resilience Ratio
SKAN Group AG (SKAN) has an Asset Resilience Ratio of 13.88% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read SKAN Group AG (SKAN) total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2024)
This chart shows how SKAN Group AG's Asset Resilience Ratio has changed over time. See SKAN Group AG (SKAN) shareholders funds for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down SKAN Group AG's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is SKAN Group AG worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CHF52.94 Million | 13.88% |
| Short-term Investments | CHF0.00 | 0% |
| Total Liquid Assets | CHF52.94 Million | 13.88% |
Asset Resilience Insights
- Moderate Liquidity: SKAN Group AG has 13.88% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
SKAN Group AG Industry Peers by Asset Resilience Ratio
Compare SKAN Group AG's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Alcon AG
SW:ALC |
Medical Instruments & Supplies | 0.26% |
|
iRay Technology Co Ltd
SHG:688301 |
Medical Instruments & Supplies | 0.68% |
|
Anbio Biotechnology Class A Ordinary Shares
NASDAQ:NNNN |
Medical Instruments & Supplies | 29.19% |
|
Jiangsu Nanfang Medical
SHG:603880 |
Medical Instruments & Supplies | 2.27% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 6.36% |
|
I.Ceram SA
PA:ALICR |
Medical Instruments & Supplies | -1.61% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 4.42% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 51.82% |
Annual Asset Resilience Ratio for SKAN Group AG (2016–2024)
The table below shows the annual Asset Resilience Ratio data for SKAN Group AG.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 16.05% | CHF61.71 Million ≈ $78.02 Million |
CHF384.49 Million ≈ $486.09 Million |
-6.72pp |
| 2023-12-31 | 22.77% | CHF85.03 Million ≈ $107.50 Million |
CHF373.45 Million ≈ $472.14 Million |
-12.25pp |
| 2022-12-31 | 35.02% | CHF135.98 Million ≈ $171.92 Million |
CHF388.35 Million ≈ $490.98 Million |
-4.58pp |
| 2021-12-31 | 39.60% | CHF131.43 Million ≈ $166.16 Million |
CHF331.92 Million ≈ $419.64 Million |
+15.06pp |
| 2020-12-31 | 24.54% | CHF63.68 Million ≈ $80.51 Million |
CHF259.54 Million ≈ $328.12 Million |
+22.92pp |
| 2019-12-31 | 1.62% | CHF1.82 Million ≈ $2.30 Million |
CHF112.57 Million ≈ $142.32 Million |
+1.20pp |
| 2018-12-31 | 0.42% | CHF406.90K ≈ $514.43K |
CHF96.50 Million ≈ $122.00 Million |
-11.66pp |
| 2017-12-31 | 12.08% | CHF10.55 Million ≈ $13.34 Million |
CHF87.35 Million ≈ $110.44 Million |
-3.00pp |
| 2016-12-31 | 15.08% | CHF10.87 Million ≈ $13.74 Million |
CHF72.08 Million ≈ $91.13 Million |
-- |
About SKAN Group AG
SKAN Group AG, together with its subsidiaries, provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally. It operates in two segments, Equipment and Solutions; and Services and Consumables. The company offers accessories, biological indicators, digital ventures, isolators, cleanroom, laminar f… Read more